Immediate Effects of Ankle Joint Mobilization on Jump Performance in Healthy University Students

July 14, 2026 updated by: Burhan Taşkaya, Muş Alparslan University

Immediate Effects of Ankle Joint Mobilization on Countermovement Jump Performance and Dorsiflexion Range of Motion in Healthy University Students

The purpose of this randomized controlled study is to investigate the immediate effects of ankle joint mobilization on countermovement jump performance and ankle dorsiflexion range of motion in healthy university students. Participants will be randomly assigned to either an ankle joint mobilization group or a sham mobilization group. Countermovement jump performance will be assessed using the My Jump Lab mobile application, and ankle dorsiflexion range of motion will be measured using the weight-bearing lunge test with a digital inclinometer before and immediately after the intervention. The findings of this study are expected to improve the understanding of the acute effects of ankle joint mobilization on functional performance and ankle mobility.

Study Overview

Detailed Description

Vertical jump performance is an important indicator of lower-extremity explosive power and neuromuscular function. Adequate ankle dorsiflexion range of motion plays a critical role in force production, movement efficiency, and landing mechanics during jumping tasks. Previous studies have demonstrated that ankle joint mobilization can improve dorsiflexion range of motion through mechanical and neurophysiological mechanisms. However, limited evidence exists regarding whether these immediate improvements in ankle mobility translate into enhanced jump performance in healthy individuals.

This randomized controlled study aims to evaluate the immediate effects of ankle joint mobilization on countermovement jump performance and ankle dorsiflexion range of motion in healthy university students.

Approximately 50 healthy university students will be recruited and randomly allocated to either an ankle joint mobilization group or a sham mobilization group (25 participants per group). Before the intervention, all participants will undergo assessments of countermovement jump performance using the My Jump Lab mobile application and ankle dorsiflexion range of motion using the weight-bearing lunge test with a digital inclinometer.

Participants in the intervention group will receive ankle joint mobilization using the Mobilization with Movement (MWM) technique. Participants in the sham group will be positioned similarly and perform the same movement without the application of therapeutic posterior talar glide. Immediately after the intervention, all outcome measures will be repeated using the same standardized procedures.

The primary outcome will be countermovement jump performance, while the secondary outcome will be ankle dorsiflexion range of motion. The results of this study may provide evidence regarding the immediate effects of ankle joint mobilization on functional performance and may contribute to the development of evidence-based manual therapy interventions for improving lower-extremity performance

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Muş
      • Muş, Muş, Turkey (Türkiye), 49250
        • Muş Alparslan University, Vocational School of Health Services
        • Contact:
        • Principal Investigator:
          • Burhan Taşkaya, PhD
        • Sub-Investigator:
          • Cengiz Taşkaya, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy university students aged 18-30 years.
  • Willing to participate and provide written informed consent.
  • No history of lower extremity musculoskeletal injury or surgery within the -previous 6 months.
  • No neurological or vestibular disorders affecting balance or movement.
  • No contraindications to manual therapy.

Exclusion Criteria:

  • Current pain in the lower extremity or spine.
  • History of ankle fracture or surgery.
  • Acute lower extremity injury within the previous 6 months.
  • Any systemic, neurological, or rheumatological disease affecting movement.
  • Participation in another intervention study during the study period.
  • Inability to complete the assessment procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobilization with Movement (MWM)
Participants assigned to this group will receive ankle joint mobilization using the Mobilization with Movement (MWM) technique. A sustained posterior talar glide will be applied while participants actively perform a weight-bearing lunge movement. The intervention will consist of three sets of ten repetitions, with a 2-3 second hold at the end range of each repetition.
A Mulligan Mobilization with Movement technique will be applied to the talocrural joint. During active weight-bearing lunge movement, a sustained posterior talar glide will be applied by the therapist. The intervention will consist of three sets of ten repetitions.
Sham Comparator: Sham Mobilization
Participants assigned to this group will undergo the same positioning and active weight-bearing lunge movement as the experimental group. However, no therapeutic posterior talar glide will be applied. This procedure is designed to mimic the intervention without providing a therapeutic mobilization effect.
Participants will perform the same active movement in the same position as the experimental group. The therapist will maintain hand contact without applying a therapeutic posterior talar glide.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement Jump Performance
Time Frame: Immediately before the intervention and immediately after the intervention (single session).
Countermovement jump (CMJ) performance will be assessed using the My Jump Lab mobile application. Participants will perform three maximal countermovement jumps with their hands on their hips, and the highest jump height (cm) will be recorded.
Immediately before the intervention and immediately after the intervention (single session).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ankle Dorsiflexion Range of Motion
Time Frame: Immediately before the intervention and immediately after the intervention (single session)
Ankle dorsiflexion range of motion will be measured using the weight-bearing lunge test with a digital inclinometer. Three measurements will be obtained, and the average value (degrees) will be used for analysis.
Immediately before the intervention and immediately after the intervention (single session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Burhan Taşkaya, Muş Alparslan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 25, 2026

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

August 15, 2026

Study Registration Dates

First Submitted

July 14, 2026

First Submitted That Met QC Criteria

July 14, 2026

First Posted (Actual)

July 17, 2026

Study Record Updates

Last Update Posted (Actual)

July 17, 2026

Last Update Submitted That Met QC Criteria

July 14, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because the study involves a limited number of participants and no consent for public sharing of anonymized individual-level data was obtained. Aggregate study results will be reported in scientific publications.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Mobilization with Movement (MWM)

3
Subscribe